The role of innate immunity in atherogenesis

Journal of Lipid Research

Volumn 50, Issue SUPPL., 2009, Pages

  Hartvigsen, Karsten ^a   Chou, Meng Yun ^a   Hansen, Lotte F ^a   Shaw, Peter X ^a   Tsimikas, Sotirios ^a   Binder, Christoph J ^a,b,c   Witztum, Joseph L ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Natural antibodies; Oxidation specific epitopes; Oxidized LDL; Oxidized lipids; Scavenger receptors

Indexed keywords

EPITOPE; PATTERN RECOGNITION RECEPTOR;

ADAPTATION; ANIMAL; ATHEROSCLEROSIS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; OXIDATION REDUCTION REACTION; REVIEW;

ADAPTATION, BIOLOGICAL; ANIMALS; ATHEROSCLEROSIS; EPITOPES; HUMANS; IMMUNITY, INNATE; OXIDATION-REDUCTION; RECEPTORS, PATTERN RECOGNITION;

EID: 66349096056     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R800100-JLR200     Document Type: Review

References (51)

1. Binder, C. J., M. K. Chang, P. X. Shaw, Y. I. Miller, K. Hartvigsen, A. Dewan, and J. L. Witztum. 2002. Innate and acquired immunity in atherogenesis. Nat. Med. 8: 1218-1226. (Pubitemid 35373552)
2. Hansson, G. K., and P. Libby. 2006. The immune response in atherosclerosis: a double-edged sword. Nat. Rev. Immunol. 6: 508-519. (Pubitemid 43980523)
3. Getz, G. S. 2005. Thematic review series: the immune system and atherogenesis. Immune function in atherogenesis. J. Lipid Res. 46:1-10.
4. Binder, C. J., P. X. Shaw, M. K. Chang, A. Boullier, K. Hartvigsen, S. Hörkkö, Y. I. Miller, D. A. Woelkers, M. Corr, and J. L. Witztum. 2005. The role of natural antibodies in atherogenesis. J. Lipid Res. 46: 1353-1363. (Pubitemid 43109798)
5. Wright, S. D., C. Burton, M. Hernandez, H. Hassing, J. Montenegro, S. Mundt, S. Patel, D. J. Card, A. Hermanowski-Vosatka, J. D. Bergstrom, et al. 2000. Infectious agents are not necessary for murine atherogenesis. J. Exp. Med. 191: 1437-1442.
6. Palinski, W., S. Ylä-Herttuala, M. E. Rosenfeld, S. W. Butler, S. A. Socher, S. Parthasarathy, L. K. Curtiss, and J. L. Witztum. 1990. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis. 10: 325-335. (Pubitemid 20178661)
7. Palinski, W., S. Hörkkö, E. Miller, U. P. Steinbrecher, H. C. Powell, L. K. Curtiss, and J. L. Witztum. 1996. Cloning of monoclonal auto-antibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J. Clin. Invest. 98: 800-814. (Pubitemid 26349186)
8. Rosenfeld, M. E., W. Palinski, S. Ylä-Herttuala, S. Butler, and J. L. Witztum. 1990. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis. 10: 336-349. (Pubitemid 20178662)
9. Horie, K., T. Miyata, K. Maeda, S. Miyata, S. Sugiyama, H. Sakai, C. Y. Strihou, V. M. Monnier, J. L. Witztum, and K. Kurokawa. 1997. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J. Clin. Invest. 100: 2995-3004. (Pubitemid 28022836)
10. Neale, T. J., P. P. Ojha, M. Exner, H. Poczewski, B. Ruger, J. L. Witztum, P. Davis, and D. Kerjaschki. 1994. Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen. J. Clin. Invest. 94: 1577-1584. (Pubitemid 24309880)
11. Dei, R., A. Takeda, H. Niwa, M. Li, Y. Nakagomi, M. Watanabe, T. Inagaki, Y. Washimi, Y. Yasuda, K. Horie, et al. 2002. Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease. Acta Neuropathol. 104: 113-122. (Pubitemid 36075368)
12. Chang, M. K., C. Bergmark, A. Laurila, S. Hörkkö, K. H. Han, P. Friedman, E. A. Dennis, and J. L. Witztum. 1999. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: Evidence that oxidation-specific epitopes mediate macrophage recognition. Proc. Natl. Acad. Sci. USA. 96: 6353-6358. (Pubitemid 29256669)
13. Tsimikas, S., E. S. Brilakis, R. J. Lennon, E. R. Miller, J. L. Witztum, J. P. McConnell, K. S. Kornman, and P. B. Berger. 2007. Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events. J. Lipid Res. 48: 425-433. (Pubitemid 46220609)
14. Binder, C. J., K. Hartvigsen, and J. L. Witztum. 2007. Promise of immune modulation to inhibit atherogenesis. J. Am. Coll. Cardiol. 50: 547-550.
15. Nilsson, J., G. K. Hansson, and P. K. Shah. 2005. Immunomodulation of atherosclerosis: implications for vaccine development. Arterioscler. Thromb. Vasc. Biol. 25: 18-28. (Pubitemid 40054250)
16. Caligiuri, G., J. Khallou-Laschet, M. Vandaele, A. T. Gaston, S. Delignat, C. Mandet, H. V. Kohler, S. V. Kaveri, and A. Nicoletti. 2007. Phosphorylcholine-targeting immunization reduces atherosclerosis. J. Am. Coll. Cardiol. 50: 540-546. (Pubitemid 47126777)
17. Hörkkö, S., D. A. Bird, E. Miller, H. Itabe, N. Leitinger, G. Subbanagounder, J. A. Berliner, P. Friedman, E. A. Dennis, L. K. Curtiss, et al. 1999. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J. Clin. Invest. 103: 117-128. (Pubitemid 29031170)
18. Shaw, P. X., S. Horkko, M. K. Chang, L. K. Curtiss, W. Palinski, G. J. Silverman, and J. L. Witztum. 2000. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Invest. 105: 1731-1740.
19. Friedman, P., S. Hörkkö, D. Steinberg, J. L.Witztum, and E. A. Dennis. 2002. Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol concentration. J. Biol. Chem. 277:7010-7020. (Pubitemid 34953088)
20. Boullier, A., K. L. Gillotte, S. Hörkkö, S. R. Green, P. Friedman, E. A. Dennis, J. L. Witztum, D. Steinberg, and O. Quehenberger. 2000. The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein. J. Biol. Chem. 275: 9163-9169. (Pubitemid 30185132)
21. Gillotte-Taylor, K., A. Boullier, J. L. Witztum, D. Steinberg, and O. Quehenberger. 2001. Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein. J. Lipid Res. 42: 1474-1482. (Pubitemid 34007679)
22. Boullier, A., P. Friedman, R. Harkewicz, K. Hartvigsen, S. R. Green, F. Almazan, E. A. Dennis, D. Steinberg, J. L. Witztum, and O. Quehenberger. 2005. Phosphocholine as a pattern recognition ligand for CD36. J. Lipid Res. 46: 969-976.
23. Hardy, R. R., C. J. Wei, and K. Hayakawa. 2004. Selection during development of VH111 B cells: a model for natural autoantibody-producing CD51 B cells. Immunol. Rev. 197: 60-74. (Pubitemid 38142168)
24. Yang, Y., J. W. Tung, E. E. B. Ghosn, L. A. Herzenberg, and L. A. Herzenberg. 2007. Division and differentiation of natural antibody-producing cells in mouse spleen. Proc. Natl. Acad. Sci. USA. 104:4542-4546. (Pubitemid 47186261)
25. Binder, C. J., M. Y. Chou, L. Fogelstrand, K. Hartvigsen, P. X. Shaw, A. Boullier, and J. L. Witztum. 2008. Natural antibodies in murine atherosclerosis. Curr. Drug Targets. 9: 190-195. (Pubitemid 351843599)
26. Baumgarth, N., J. W. Tung, and L. A. Herzenberg. 2005. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin. Immunopathol. 26: 347-362. (Pubitemid 40468889)
27. Mi, Q. S., L. Zhou, D. H. Schulze, R. T. Fischer, A. Lustig, L. J. Rezanka, D. M. Donovan, D. L. Longo, and J. J. Kenny. 2000. Highly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse. Proc. Natl. Acad. Sci. USA. 97:6031-6036. (Pubitemid 30367518)
28. Chang, M. K., C. J. Binder, Y. I. Miller, G. Subbanagounder, G. J. Silverman, J. A. Berliner, and J. L. Witztum. 2004. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J. Exp. Med. 200: 1359-1370. (Pubitemid 39657284)
29. Binder, C. J., S. Hörkkö, A. Dewan, M. K. Chang, E. P. Kieu, C. S. Goodyear, P. X. Shaw, W. Palinski, J. L. Witztum, and G. J. Silverman. 2003. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat. Med. 9: 736-743. (Pubitemid 36749223)
30. Faria-Neto, J. R., K. Y. Chyu, X. Li, P. C. Dimayuga, C. Ferreira, J. Yano, B. Cercek, and P. K. Shah. 2005. Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice. Atherosclerosis. 189: 83-90. (Pubitemid 44468069)
31. Huber, J., A. Vales, G. Mitulovic, M. Blumer, R. Schmid, J. L. Witztum, B. R. Binder, and N. Leitinger. 2002. Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions. Arterioscler. Thromb. Vasc. Biol. 22: 101-107. (Pubitemid 34076239)
32. Imai, Y., K. Kuba, G. G. Neely, R. Yaghubian-Malhami, T. Perkmann, G. van Loo, M. Ermolaeva, R. Veldhuizen, Y. H. C. Leung, H. Wang, et al. 2008. Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 133: 235-249. (Pubitemid 351512299)
33. Tuominen, A., Y. I.Miller, L. F. Hansen, Y. A. Kesaniemi, J. L. Witztum, and S. Hörkkö. 2006. A natural antibody to oxidized cardiolipin binds to oxidized low-density lipoprotein, apoptotic cells, and atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 26: 2096-2102. (Pubitemid 44253794)
34. Kagan, V. E., G. G. Borisenko, Y. Y. Tyurina, V. A. Tyurin, J. Jiang, A. I. Potapovich, V. Kini, A. A. Amoscato, and Y. Fujii. 2004. Oxidative lipidomics of apoptosis: redox catalytic interactions of cytochrome c with cardiolipin and phosphatidylserine. Free Radic. Biol. Med. 37:1963-1985. (Pubitemid 39491317)
35. Goldstein, J. L., Y. K. Ho, S. K. Basu, and M. S. Brown. 1979. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA. 76: 333-337. (Pubitemid 9110191)
36. Pluddemann, A., C. Neyen, and S. Gordon. 2007. Macrophage scavenger receptors and host-derived ligands. Methods. 43: 207-217. (Pubitemid 47499075)
37. Krieger, M. 1992. Molecular flypaper and atherosclerosis: structure of themacrophage scavenger receptor. Trends Biochem. Sci. 17: 141-146.
38. Pluddemann, A., S. Mukhopadhyay, and S. Gordon. 2006. The interaction of macrophage receptors with bacterial ligands. Expert Rev. Mol. Med. 8: 1-25. (Pubitemid 44830941)
39. Miller, Y. I., S. Viriyakosol, D. S. Worrall, A. Boullier, S. Butler, and J. L. Witztum. 2005. Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler. Thromb. Vasc. Biol. 25: 1213-1219. (Pubitemid 40776611)
40. Erridge, C., S. Kennedy, C. M. Spickett, and D. J. Webb. 2008. Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition. J. Biol. Chem. 283:24748-24759.
41. Walton, K. A., X. Hsieh, N. Gharavi, S. Wang, G. Wang, M. Yeh, A. L. Cole, and J. A. Berliner. 2003. Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine-mediated synthesis of interleukin-8. A role for Toll-like receptor 4 and a glycosylphosphatidylinositol-anchored protein. J. Biol. Chem. 278: 29661-29666. (Pubitemid 36962351)
42. Hazen, S. L. 2008. Oxidized phospholipids as endogenous pattern recognition ligands in innate immunity. J. Biol. Chem. 283:15527-15531.
43. Greenberg, M. E., M. Sun, R. Zhang, M. Febbraio, R. Silverstein, and S. L. Hazen. 2006. Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J. Exp. Med. 203: 2613-2625. (Pubitemid 44833338)
44. Freeman, M., Y. Ekkel, L. Rohrer, M. Penman, N. J. Freedman, G. M. Chisolm, and M. Krieger. 1991. Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA. 88: 4931-4935. (Pubitemid 21914657)
45. Chang, M. K., C. J. Binder, M. Torzewski, and J. L. Witztum. 2002. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids. Proc. Natl. Acad. Sci. USA. 99: 13043-13048.
46. Griselli, M., J. Herbert, W. L. Hutchinson, K. M. Taylor, M. Sohail, T. Krausz, and M. B. Pepys. 1999. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J. Exp. Med. 190: 1733-1740.
47. Savill, J., I. Dransfield, C. Gregory, and C. Haslett. 2002. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2: 965-975. (Pubitemid 37323217)
48. Ogden, C. A., R. Kowalewski, Y. Peng, V. Montenegro, and K. B. Elkon. 2005. IGM is required for efficient complement mediated phagocytosis of apoptotic cells in vivo. Autoimmunity. 38: 259-264. (Pubitemid 40974955)
49. Tsimikas, S., Y. T. Lau, K. H. Han, B. P. Shortal, E. Miller, A. Segev, L. K. Curtiss, J. L. Witztum, and B. H. Strauss. 2004. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and Lp(a): acute and long term immunological responses to oxidized LDL. Circulation. 109: 3164-3170.
50. Briley-Saebo, K. C., P. X. Shaw, W. J. Mulder, S. H. Choi, E. Vucic, J. G. Aguinaldo, J. L. Witztum, V. Fuster, S. Tsimikas, and Z. A. Fayad. 2008. Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes. Circulation. 117: 3206-3215.
51. Chou, M. Y., K. Hartvigsen, L. F. Hansen, L. Fogelstrand, P. X. Shaw, A. Boullier, C. J. Binder, and J. L. Witztum. 2008. Oxidation-specific epitopes are important targets of innate immunity. J. Intern. Med. 263: 479-488. (Pubitemid 351533561)